Send to:

Choose Destination
See comment in PubMed Commons below
J Neuroimmunol. 2010 Jun;223(1-2):13-9. doi: 10.1016/j.jneuroim.2010.03.018. Epub 2010 Apr 22.

Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.

Author information

  • 1Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA.


Patients with systemic lupus erythematosus (SLE) often suffer from depression and fatigue in addition to the physical manifestations of the autoimmune disease. Elevated production of type-I interferons (IFN-I) has been found in lupus patients and IFN-I can precipitate a variety of neuropsychiatric side effects. This study was conducted to evaluate the relationship between dysregulated IFN-I production and the presence of depression or fatigue in lupus patients. Through cross-sectional and longitudinal analysis we found no significant correlation between abnormal IFN-I levels (as measured by peripheral blood expression of IFN-I-stimulated genes) and neuropsychiatric manifestations. Elevation of endogenous serum IFN-I levels is unlikely to account for the depression and fatigue associated with SLE.

Copyright 2010. Published by Elsevier B.V. All rights reserved.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk